Sarepta Therapeutics Inc (SRPT)

77.70 -0.29  -0.37% NASDAQ Oct 27, 10:27 USD
View Full Chart
Price Chart
View All SRPT News

News

View All Events

Events

Date Type Description
11/05/2021 Earnings Results Q3 2021 Earnings Results
11/05/2021 16:30 EST Earnings Calls Q3 2021 Earnings Call
08/04/2021 Earnings Results Q2 2021 Earnings Results
08/04/2021 16:30 EST Earnings Calls Q2 2021 Earnings Call
06/03/2021 09:00 EST AGM 2020 Annual General Meeting
05/05/2021 Earnings Results Q1 2021 Earnings Results
05/05/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
03/01/2021 Earnings Results Q4 2020 Earnings Results
03/01/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.
  • URL: https://www.sarepta.com
  • Investor Relations URL: https://investorrelations.sarepta.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Nov. 05, 2021
  • Last Earnings Release: Aug. 04, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
GNOM Global X Genomics & Biotechnology ETF 4.92%
IDNA iShares Genomics Immnlgy & Hlthcr ETF 4.10%
CIB158 CIBC Global Technology F 3.24%
ATL1745 Renaissance Global Science & Tech Cl O 3.24%
FBT First Trust NYSE Arca Biotech ETF 3.18%
DBMCX BNY Mellon Sm/Md Cp Gr C 1.82%
TSNCX Touchstone Sands Capital Select Growth C 1.75%
JFNSX Janus Henderson Global Life Sciences S 1.36%
FIJYX Fidelity Advisor® Biotechnology Z 1.05%
BTEC Principal Healthcare Innovators Idx ETF 0.93%
ISCG iShares Morningstar Small-Cap Growth ETF 0.34%
BKSE BNY Mellon US Small Cap Core Equity ETF 0.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.